2,191
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Comparison of rapid molecular testing methods for detecting respiratory viruses in emergency care: a prospective study

, , , , , , , & show all
Pages 247-254 | Received 01 Jun 2021, Accepted 03 Nov 2021, Published online: 30 Nov 2021

References

  • Silka PA, Geiderman JM, Goldberg JB, et al. Demand on ED resources during periods of widespread influenza activity. Am J Emerg Med. 2003;21(7):534–539.
  • Royston L, Tapparel C. Rhinoviruses and respiratory enteroviruses: not as simple as ABC. Viruses. 2016;8(1):16.
  • Nabeya D, Kinjo T, Parrott GL, et al. The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit. J Med Virol. 2017;89(8):1364–1372.
  • Piralla A, Percivalle E, Di Cesare-Merlone A, et al. Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study. Haematologica. 2009;94(6):833–839.
  • Hagihara M, Kato Y, Kurumiya A, et al. The prophylactic effect of anti-influenza agents for an influenza outbreak in a university hospital. Intern Med. 2018;57(4):497–501.
  • Hoellein A, Hecker J, Hoffmann D, et al. Serious outbreak of human metapneumovirus in patients with hematologic malignancies. Leuk Lymphoma. 2016;57(3):623–627.
  • Siegel JD, Rhinehart E, Jackson M, et al. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10):S65–S164.
  • Stott DJ, Kerr G, Carman WF. Nosocomial transmission of influenza. Occup Med (Lond). 2002;52(5):249–253.
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in wuhan, China. JAMA. 2020;323(11):1061.
  • Spencer S, Thompson MG, Flannery B, et al. Comparison of respiratory specimen collection methods for detection of influenza virus infection by reverse Transcription-PCR: a literature review. J Clin Microbiol 2019;57(9):e00027–19.
  • Kanwar N, Michael J, Doran K, et al. Comparison of the ID now influenza A & B 2 Cobas influenza A/B, and Xpert Xpress flu point-of-care nucleic acid amplification tests for influenza A/B virus detection in children. J Clin Microbiol. 2020;58(3):e01611-19.
  • Loens K, Van Heirstraeten L, Malhotra-Kumar S, et al. Optimal sampling sites and methods for detection of pathogens possibly causing Community-Acquired lower respiratory tract infections. J Clin Microbiol. 2009;47(1):21–31.
  • Vemula SV, Zhao J, Liu J, et al. Current approaches for diagnosis of influenza virus infections in humans. Viruses. 2016;8(4):96–96.
  • Falsey AR, Formica MA, Walsh EE. Yield of sputum for viral detection by reverse transcriptase PCR in adults hospitalized with respiratory illness. J Clin Microbiol. 2012;50(1):21–24.
  • Bogoch II, Andrews JR, Zachary KC, et al. Diagnosis of influenza from lower respiratory tract sampling after negative upper respiratory tract sampling. Virulence. 2013;4(1):82–84.
  • Gilbert DN, Leggett JE, Wang L, et al. Enhanced detection of Community-Acquired pneumonia pathogens with the BioFire® pneumonia FilmArray® panel. Diagn Microbiol Infect Dis. 2021;99(3):115246.
  • Buchan BW, Windham S, Balada-Llasat JM, et al. Practical comparison of the BioFire FilmArray pneumonia panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. J Clin Microbiol. 2020;58(0):e00135-20.
  • Murphy CN, Fowler R, Balada-Llasat JM, et al. Multicenter evaluation of the BioFire FilmArray pneumonia/pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microbiol. 2020;58(7):e00128-20.
  • BioFire, BioFire® FilmArray® pneumonia panel plus instruction booklet BioFire, editor. Biomérieux. 2019. p. 112. Available from: https://www.biofiredx.com/support/documents/
  • Abbot. INSTRUMENT USER MANUAL ID NOW. Rev. 12 2021/02 [cited 2021 Jul 1]. Available from: https://ensur.invmed.com/ensur/broker/ensurbroker.aspx?code=INNAT000&cs=27237221
  • WHO. Clinical management of COVID-19. Geneva, Switzerland: WHO; 2020. p. 62.
  • Lee N, Walsh EE, Sander I, et al. Delayed diagnosis of respiratory syncytial virus infections in hospitalized adults: individual patient data, record review analysis and physician survey in the United States. J Infect Dis. 2019;220(6):969–979.
  • Ko F, Drews SJ. The impact of commercial rapid respiratory virus diagnostic tests on patient outcomes and health system utilization. Expert Rev Mol Diagn. 2017;17(10):917–931.
  • Rappo U, Schuetz AN, Jenkins SG, et al. Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients. J Clin Microbiol. 2016;54(8):2096–2103.
  • Abbot. ID NOW™ INFLUENZA A & B 2, specifications. [cited 2020 Mar 23]. Available from: https://www.alere.com/en/home/product-details/id-now-influenza-ab-2.html
  • Chapin KC, Flores-Cortez EJ, Loeffelholz MJ. Performance of the molecular Alere I influenza A&B test compared to that of the Xpert flu A/B assay. J Clin Microbiol. 2015;53(2):706–709.
  • Nolte FS, Gauld L, Barrett SB. Direct comparison of Alere I and Cobas liat influenza a and B tests for rapid detection of influenza virus infection. J Clin Microbiol. 2016;54(11):2763–2766.
  • Lephart PR, Bachman MA, LeBar W, et al. Comparative study of four SARS-CoV-2 nucleic acid amplification test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type. Diagn Microbiol Infect Dis. 2021;99(1):115200.
  • Farfour E, Roux A, Ballester M, et al. Improved performances of the second generation of the ID NOW influenza A&B 2® and comparison with the GeneXpert®. Eur J Clin Microbiol Infect Dis. 2020;39(9):1681–1686.
  • Teoh TK, Powell J, Kelly J, et al. Outcomes of point-of-care testing for influenza in the emergency department of a tertiary referral hospital in Ireland. J Hosp Infect. 2021;110:45–51.
  • Jeong JH, Kim KH, Jeong SH, et al. Comparison of sputum and nasopharyngeal swabs for detection of respiratory viruses. J Med Virol 2014;86(12):2122–2127.
  • Young S, Illescas P, Nicasio J, et al. Diagnostic accuracy of the real-time PCR cobas® liat® influenza a/B assay and the Alere I influenza a&B near isothermal nucleic acid amplification assay for the detection of influenza using adult nasopharyngeal specimens. J Clin Virol. 2017;94:86–90.
  • Yu F, Yan L, Wang N, et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis. 2020;71(15):793–798.
  • Torres A, Loeches IM, Sligl W, et al. Severe flu management: a point of view. Intensive Care Med. 2020;46(2):153–162.
  • Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan). 2020;12:11.
  • Broder K, Babiker A, Myers C, et al. Test agreement between Roche Cobas 6800 and cepheid GeneXpert Xpress SARS-CoV-2 assays at high cycle threshold ranges. J Clin Microbiol. 2020;58(8):e01187–20.
  • Sprague E, Reynolds S, Brindley P. Patient isolation precautions: are they worth it? Can Respir J. 2016;2016:5352625–5352625.
  • Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA. 2003;290(14):1899–1905.